These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 8060802

  • 1. Clinical review of lansoprazole.
    Lockhart SP.
    Br J Clin Pract Suppl; 1994; 75():48-55; discussion 56-7. PubMed ID: 8060802
    [Abstract] [Full Text] [Related]

  • 2. [Lansoprazole--profile of a new proton pump inhibitor].
    Seifert E.
    Leber Magen Darm; 1994 Mar; 24(2):66-8, 71. PubMed ID: 8196467
    [Abstract] [Full Text] [Related]

  • 3. Treatment of reflux esophagitis resistant to H2-receptor antagonists with lansoprazole, a new H+/K(+)-ATPase inhibitor: a controlled, double-blind study. Lansoprazole Study Group.
    Feldman M, Harford WV, Fisher RS, Sampliner RE, Murray SB, Greski-Rose PA, Jennings DE.
    Am J Gastroenterol; 1993 Aug; 88(8):1212-7. PubMed ID: 8101695
    [Abstract] [Full Text] [Related]

  • 4. [Lansoprazol].
    Ponce J, Nos P.
    Gastroenterol Hepatol; 1995 Feb; 18(2):101-9. PubMed ID: 7621274
    [No Abstract] [Full Text] [Related]

  • 5. Progress with proton pump inhibitors in acid peptic disease: treatment of duodenal and gastric ulcer.
    Florent C.
    Clin Ther; 1993 Feb; 15 Suppl B():14-21. PubMed ID: 7911399
    [Abstract] [Full Text] [Related]

  • 6. [Double-blind controlled-clinical trials of lansoprazole in the treatment of peptic ulcer].
    Ogawa N.
    Nihon Rinsho; 1992 Jan; 50(1):68-73. PubMed ID: 1347332
    [Abstract] [Full Text] [Related]

  • 7. Meta-analysis of randomized clinical trials comparing lansoprazole with ranitidine or famotidine in the treatment of acute duodenal ulcer.
    Poynard T, Lemaire M, Agostini H.
    Eur J Gastroenterol Hepatol; 1995 Jul; 7(7):661-5. PubMed ID: 8590162
    [Abstract] [Full Text] [Related]

  • 8. Lansoprazole: a comprehensive review.
    Zimmermann AE, Katona BG.
    Pharmacotherapy; 1997 Jul; 17(2):308-26. PubMed ID: 9085323
    [Abstract] [Full Text] [Related]

  • 9. Reflux oesophagitis and its treatment.
    Long RG.
    Br J Clin Pract Suppl; 1994 Jul; 75():36-9; discussion 40. PubMed ID: 8060800
    [No Abstract] [Full Text] [Related]

  • 10. Lansoprazole--a new proton pump inhibitor.
    Ahmed W, Ali A, Qureshi H, Zuberi SJ, Shamsi ZU.
    J Pak Med Assoc; 1995 May; 45(5):144-5. PubMed ID: 7563582
    [No Abstract] [Full Text] [Related]

  • 11. Bedtime administration of lansoprazole does not modify its greater efficacy vs ranitidine in the acute and long-term treatment of duodenal ulcer. Results from a multicentre, randomised, double blind clinical trial.
    Russo A, Dattilo M.
    Ital J Gastroenterol Hepatol; 1997 Aug; 29(4):312-9. PubMed ID: 9476183
    [Abstract] [Full Text] [Related]

  • 12. An overview of the pharmacology, efficacy, safety and cost-effectiveness of lansoprazole.
    Bown RL.
    Int J Clin Pract; 2002 Mar; 56(2):132-9. PubMed ID: 11926700
    [Abstract] [Full Text] [Related]

  • 13. Lansoprazole. A review of its pharmacodynamic and pharmacokinetic properties and its therapeutic efficacy in acid-related disorders.
    Barradell LB, Faulds D, McTavish D.
    Drugs; 1992 Aug; 44(2):225-50. PubMed ID: 1382017
    [Abstract] [Full Text] [Related]

  • 14. Lansoprazole heals erosive reflux esophagitis resistant to histamine H2-receptor antagonist therapy.
    Sontag SJ, Kogut DG, Fleischmann R, Campbell DR, Richter J, Robinson M, McFarland M, Sabesin S, Lehman GA, Castell D.
    Am J Gastroenterol; 1997 Mar; 92(3):429-37. PubMed ID: 9068463
    [Abstract] [Full Text] [Related]

  • 15. Lansoprazole: a proton pump inhibitor.
    Garnett WR.
    Ann Pharmacother; 1996 Dec; 30(12):1425-36. PubMed ID: 8968456
    [Abstract] [Full Text] [Related]

  • 16. [Cost-effectiveness of the treatment of reflux esophagitis: proton pump inhibitor versus histamine-2-receptor antagonist].
    Habu Y, Oyasu K, Wakamatsu T, Sumitomo Y, Kiyota K, Inokuchi H, Kawai K.
    Nihon Rinsho; 2000 Sep; 58(9):1881-5. PubMed ID: 11004820
    [Abstract] [Full Text] [Related]

  • 17. [A clinical trial of lansoprazole in the treatment of duodenal ulcer].
    Pei Y, Wang B, Chen S.
    Zhonghua Nei Ke Za Zhi; 1995 Sep; 34(9):606-8. PubMed ID: 8697927
    [Abstract] [Full Text] [Related]

  • 18. [Lansoprazol ++ : a new proton pump inhibitor].
    Baczek J, Laskowiec G.
    Pol Merkur Lekarski; 1998 Jun; 4(24):339-41. PubMed ID: 9771021
    [Abstract] [Full Text] [Related]

  • 19. [Effectiveness and safety of lansoprazole in the treatment of peptic ulcer].
    Ramón Nogueira J, Esquivel Ayanegui F, Esquivel Rodríguez F, Sáenz V, Santoyo R.
    Rev Gastroenterol Mex; 1996 Jun; 61(4):314-9. PubMed ID: 9072782
    [Abstract] [Full Text] [Related]

  • 20. [Results of pre- and postoperative treatment of complicated duodenal ulcers with proton pump inhibitors ].
    Cherniakevich SA, Babkova IV, Mikhalev AI.
    Klin Med (Mosk); 2002 Jun; 80(9):52-4. PubMed ID: 12416227
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.